H. Le Roux Jooste serves as Executive at Ocata Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, H. Le Roux Jooste has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 10, 2016 involved transacting 25,000 shares valued at $212.5K.
H. Le Roux Jooste currently holds 25,000 shares of Ocata Therapeutics, Inc. (OCAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, H. Le Roux Jooste has been a net neutral trader of OCAT stock. They have purchased $0 and sold $0 worth of shares.
H. Le Roux Jooste's most recent insider trade was on Feb 10, 2016, when they sold 25,000 shares at $8.50 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |